Innovative Industrial Properties, Inc.
$1.92B- Market cap
- $1.58B
- Debt
- +$393.72M
- Cash
- −$47.60M
Capital structure 80% equity / 20% debt · EV / Revenue 7.23x · EV / EBITDA 9.22x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: IIPR stock price vs ZOM: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ZOM's multiple
Needs ZOM P/E.
Implied fair value · at IIPR's multiple
Needs EPS (TTM) is negative, IIPR P/E.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: IIPR FY 2025 (ended Dec 31, 2025) · ZOM FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 80% equity / 20% debt · EV / Revenue 7.23x · EV / EBITDA 9.22x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Innovative Industrial Properties, Inc. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Zomedica Corp. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.21x
0.04x
Net debt / EBITDA
Leverage against operating earnings
1.66x
0.06x
Cash and equivalents
Liquid reserves on the balance sheet
$47.60M
$9.02M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
REALTY INCOME CORP
IIPR vs O
AGREE REALTY CORP
IIPR vs ADC
HEALTHPEAK PROPERTIES, INC.
IIPR vs DOC
LTC PROPERTIES INC
IIPR vs LTC
Sabra Health Care REIT, Inc.
IIPR vs SBRA
OMEGA HEALTHCARE INVESTORS INC
IIPR vs OHI
Zoetis Inc.
IIPR vs ZTS
Elanco Animal Health Inc
IIPR vs ELAN
PHIBRO ANIMAL HEALTH CORP
IIPR vs PAHC
$393.72M
$4.36M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.